Impact of postoperative omega-3 fatty acid-supplemented parenteral nutrition on clinical outcomes and immunomodulations in colorectal cancer patients

Table 4 Assessment of inflammatory and immunological parameters before and after operation in the FO group versus the SO group (mean ± SD)

Group	n	IL-6 (pg/mL)					TNF-α(pg/mL)
		POD-1	POD+1	POD+8	1	2	POD-1	POD+1	POD+8	1	2
FO	20	9.02 ± 23.25	59.66 ± 31.91	15.23 ± 8.42	50.64 ± 32.21	-44.43 ± 30.53	2.74 ± 2.00	3.31 ± 2.85	2.49 ± 2.06	0.57 ± 3.46	-0.82 ± 2.71
SO	21	10.42 ± 10.75	42.60 ± 50.12	34.21 ± 44.12	32.18 ± 47.69	-8.39 ± 69.08	2.48 ± 3.73	2.66 ± 2.76	2.94 ± 3.12	0.18 ± 4.50	0.27 ± 1.67
t		0.249	1.292	1.935	1.445	2.141	0.270	0.738	0.544	0.312	1.570
P		0.804	0.204	0.066	0.156	0.039	0.789	0.465	0.590	0.757	0.125